Hoerter Steven L.
SEC insider (Form 3/4/5 filer). CIK 0001533451. President and CEO at MBX Biosciences, Inc. (MBX) and 3 other issuers. 15 reported Form 4/5 transactions since Sep 2024; latest on Aug 3, 2026. Located in CARMEL, IN.
Companies Hoerter Steven L. has filed insider reports for
- MBX Biosciences, Inc. (MBX): Director, Officer, President and CEO
- Yarrow Bioscience, Inc. (YARW): Director
- C4 Therapeutics, Inc. (CCCC): Director
- Oric Pharmaceuticals, Inc. (ORIC): Director
Hoerter Steven L.
CIK: 0001533451
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Aug 3, 2026MBX
MBX Biosciences, Inc.
AwardDirect71K shares- - Jun 24, 2026CCCC
C4 Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
62K shares- - Jun 4, 2026MBX
MBX Biosciences, Inc.
AwardDirectStock option (right to buy)
12.5K shares- - May 1, 2026MBX
MBX Biosciences, Inc.
AwardDirect11.9K shares- - Jan 2, 2026ORIC
Oric Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
40K shares- - Nov 22, 2025MBX
MBX Biosciences, Inc.
AwardDirectStock option (right to buy)
0 shares- - Nov 22, 2025MBX
MBX Biosciences, Inc.
AwardDirectStock option (right to buy)
8K shares- - Nov 6, 2025MBX
MBX Biosciences, Inc.
AwardDirectStock option (right to buy)
33.8K shares- - Nov 6, 2025MBX
MBX Biosciences, Inc.
AwardDirectStock option (right to buy)
100K shares- - Oct 17, 2025MBX
MBX Biosciences, Inc.
PurchaseIndirect20K shares at avg. $13.25$265K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 3, 2026 |  MBX MBX Biosciences, Inc. | Award | 71,000 | - | $0 | Direct |
| Jun 24, 2026 |  CCCC C4 Therapeutics, Inc. | Award Stock Option (Right to Buy) | 62,000 | - | - | Direct |
| Jun 4, 2026 | MBX MBX Biosciences, Inc. | Award Stock option (right to buy) | 12,500 | - | - | Direct |
| May 1, 2026 | MBX MBX Biosciences, Inc. | Award | 11,938 | - | $0 | Direct |
| Jan 2, 2026 |  ORIC Oric Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 40,000 | - | - | Direct |
| Nov 22, 2025 | MBX MBX Biosciences, Inc. | Award Stock option (right to buy) | 0 | - | - | Direct |
| Nov 22, 2025 | MBX MBX Biosciences, Inc. | Award Stock option (right to buy) | 8,000 | - | - | Direct |
| Nov 6, 2025 | MBX MBX Biosciences, Inc. | Award Stock option (right to buy) | 33,751 | - | - | Direct |
| Nov 6, 2025 | MBX MBX Biosciences, Inc. | Award Stock option (right to buy) | 100,000 | - | - | Direct |
| Oct 17, 2025 | MBX MBX Biosciences, Inc. | Purchase | 20,000 | $13.25 | $264,984 | Indirect |
1-10 of 15 transactions